Adachi Y, Kamiyama H, Ichikawa K, Fukushima S, et al. Inhibition of FGFR Reactivates IFNgamma Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies. Cancer Res 2022;82:292-306.
PMID: 34753772